Current cannabis use was “consistently associated with smaller waist circumference, lower BMI, and lower risks of … obesity in patients with chronic HCV infection.”
Authors theorized that more frequent consumers were more tolerant to the effects of cannabis and also engaged in more compensatory driving behaviors.
“Extending our results to other states, we find that medical cannabis legalization has reduced auto insurance premiums by $1.5 billion in all states that have currently legalized,” authors concluded.
Investigators concluded: “[M]ost cancer comorbid symptoms improved significantly during six months of medical cannabis treatment.”
Compared to the placebo group, subjects receiving CBD extracts experienced significant improvements in their ASD symptoms.
Compared to non-users, those who consumed cannabis were more likely to be younger and were more likely to report suffering from severe pain.
Judges opined that the process used to manufacture the end product was irrelevant as long as it was initially sourced from either hemp or hemp-derived CBD.